259 related articles for article (PubMed ID: 37047172)
21. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
[TBL] [Abstract][Full Text] [Related]
22. Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle.
Al-Sayadi GMH; Verma A; Choudhary Y; Sandal P; Patel P; Singh D; Gupta GD; Kurmi BD
Pharm Nanotechnol; 2023; 11(2):138-154. PubMed ID: 36305142
[TBL] [Abstract][Full Text] [Related]
23. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status.
Liu M; Wen J; Sharma M
Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322
[TBL] [Abstract][Full Text] [Related]
24. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
25. Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications.
Alwani S; Wasan EK; Badea I
Mol Pharm; 2024 Jul; 21(7):3084-3102. PubMed ID: 38828798
[TBL] [Abstract][Full Text] [Related]
26. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
[TBL] [Abstract][Full Text] [Related]
27. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
28. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
[TBL] [Abstract][Full Text] [Related]
29. Lipid-Coated Nanosized Drug Delivery Systems for an Effective Cancer Therapy.
Esim O; Hascicek C
Curr Drug Deliv; 2021; 18(2):147-161. PubMed ID: 32394833
[TBL] [Abstract][Full Text] [Related]
30. Intracellular trafficking of solid lipid nanoparticles and their distribution between cells through tunneling nanotubes.
Kristl J; Plajnšek KT; Kreft ME; Janković B; Kocbek P
Eur J Pharm Sci; 2013 Sep; 50(1):139-48. PubMed ID: 23628779
[TBL] [Abstract][Full Text] [Related]
31. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
32. Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells.
Shah RM; Rajasekaran D; Ludford-Menting M; Eldridge DS; Palombo EA; Harding IH
Colloids Surf B Biointerfaces; 2016 Apr; 140():204-212. PubMed ID: 26764103
[TBL] [Abstract][Full Text] [Related]
33. GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting.
Jagdale S; Narwade M; Sheikh A; Md S; Salve R; Gajbhiye V; Kesharwani P; Gajbhiye KR
Int J Pharm; 2023 Apr; 637():122894. PubMed ID: 36990168
[TBL] [Abstract][Full Text] [Related]
34. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
35. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
36. Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery.
Khatak S; Dureja H
Recent Pat Nanotechnol; 2015; 9(3):150-77. PubMed ID: 27009132
[TBL] [Abstract][Full Text] [Related]
37. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate.
Mahmoudian M; Maleki Dizaj S; Salatin S; Löbenberg R; Saadat M; Islambulchilar Z; Valizadeh H; Zakeri-Milani P
Expert Opin Drug Deliv; 2021 Nov; 18(11):1707-1722. PubMed ID: 34553650
[TBL] [Abstract][Full Text] [Related]
38. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
Maurya L; Singh S; Rajamanickam VM; Narayan G
Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
[TBL] [Abstract][Full Text] [Related]
39. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
